Hudson Bay Capital Management LP Global Blood Therapeutics, Inc. Transaction History

Hudson Bay Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $1.94 Million - $4.09 Million	60,000 New	60,000 $4.09 Million
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $1.2 Million - $1.6 Million	-30,000 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$31.54 - $46.67 $1.26 Million - $1.87 Million	-40,000 Reduced 57.14%	30,000 $1.23 Million
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $2.66 Million - $3.58 Million	70,000 New	70,000 $2.66 Million
Q4 2017 Feb 12, 2018	SELL	$29.7 - $45.7 $6.68 Million - $10.3 Million	-225,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$25.1 - $31.05 $5.65 Million - $6.99 Million	225,000	225,000 $6.99 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.